已收盘 12-19 16:00:00 美东时间
-0.440
-22.91%
cbdMD (AMEX:YCBD) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 94.44 percent increase over losses of $(1.44) per share from the same
今天 05:18
cbdMD, Inc. (NYSE:YCBD), a leading wellness company and the parent of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, today announces that it has entered into securities purchase agreements
今天 04:05
Trump is expected to sign an executive order reclassifying cannabis to Schedule III, easing federal restrictions.
12-18 01:07
https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?id=128472615
12-17 21:38
U.S. stocks traded lower midway through trading, with the Nasdaq Composite fall...
12-13 01:17
cbdMD, Inc. (NYSE:YCBD), a leading innovator in wellness and hemp-derived products, is pleased to announce that it has regained full compliance with the continued listing standards of the NYSE American. As a result, the
12-09 00:10
北京时间2025年01月14日03时04分,礼来(LLY.us)股票出现异动,股价急速上涨0.08%。截至发稿,该股报800.50美元/股,成交量189.182万股,换手率0.21%,振幅2.00%。 最近的财报数据显示,该股实现营业收入114.39亿美元,净利润9.70亿美元,每股收益1.08美元,毛利92.68亿美元,市盈率86.17倍。 机构评级方面,在所有32家参与评级的机构中,78%的券商给予买入建议,19%的券商给予持有建议,3%的券商给予卖出建议。 礼来股票所在的制药行业中,整体跌幅为0.07%。其相关个股中,Intra-Cellular Therapies Inc.、Durec...
01-14 03:04
北京时间2025年01月09日03时23分,诺华制药(NVS.us)股票出现波动,股价急速上涨1.05%。截至发稿,该股报100.02美元/股,成交量102.241万股,换手率0.05%,振幅1.45%。 最近的财报数据显示,该股实现营业收入128.23亿美元,净利润31.89亿美元,每股收益1.59美元,毛利95.19亿美元,市盈率11.74倍。 机构评级方面,在所有27家参与评级的机构中,22%的券商给予买入建议,67%的券商给予持有建议,11%的券商给予卖出建议。 诺华制药股票所在的制药行业中,整体涨幅为0.47%。其相关个股中,Sunshine Biopharma Inc C/Wts ...
01-09 03:23
GAINERS: Australis Capital (OTC:AUSAF) shares closed up 1009900.00% at $0.01 G...
2024-09-19 04:30